CombinatoRx (CRXX) Posts Q3 Loss, Better Y/Y
CombinatoRx, Incorporated (NASDAQ: CRXX) reports Q3 loss of $0.24, compared to ($0.45) in the same quarter last year. Revenue for the quarter was $2.7 million, versus $3.0 million in Q308.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Monro Muffler (MNRO) Tops Q4 EPS by 1c; Comps About Flat; Guides FY13 EPS Below Views
- ATA, Inc. (ATAI) Misses Q4 EPS by 1c; Guides FY13 Revs Below
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
